Crossmark

Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers

Crossref DOI link: https://doi.org/10.1007/s12282-019-00977-0

Published Online: 2019-05-16

Published Print: 2019-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fujimoto, Yukie

Watanabe, Takahiro

Hida, Akira I.

Higuchi, Tomoko

Miyagawa, Yoshimasa

Ozawa, Hiromi

Bun, Ayako

Fukui, Reiko

Sata, Atsushi

Imamura, Michiko

Hirota, Seiichi

Miyoshi, Yasuo https://orcid.org/0000-0001-8535-4008
Funding

Funding for this research was provided by:

Ministry of Education, Culture, Sports, Science, and Technology of Japan (15K10077)
License Information

Text and Data Mining valid from 2019-05-16

Version of Record valid from 2019-05-16
More Information

Article History

Received: 14 March 2019

Accepted: 8 May 2019

First Online: 16 May 2019

Compliance with ethical standards

:

: AH received personal fees as honoraria from Chugai Pharmaceutical, Taiho Parmaceutical, and Novartis Pharma. YaM received lecture fees or grants from Chugai Pharmaceutical, AstraZeneca, Eli Lily, Phizer, Eizai, MSD, and Taiho Pharmaceutical. Other authors declare that they have no conflict of interest.

: This study was approved by the ethics committee of the Hyogo College of Medicine (No. 1886) in accordance with the Declaration of Helsinki.

: As this study collected only retrospective clinical data and offered no risk to the participants, written informed consent was not required.

Document is current

Any future updates will be listed below